How much funding has Aizen Therapeutics raised?

Aizen Therapeutics has raised $13.0M in total funding, most recently a Seed round.

Who are Aizen Therapeutics's investors?

Aizen Therapeutics's investors include Madrona Venture, Cercano Management.

When was Aizen Therapeutics founded?

Aizen Therapeutics was founded in 2022.

Where is Aizen Therapeutics headquartered?

Aizen Therapeutics is headquartered in San Diego.

What industry is Aizen Therapeutics in?

Aizen Therapeutics operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does Aizen Therapeutics have?

Aizen Therapeutics has 1-10 employees.

Aizen Therapeutics

San Diego · Founded 2022 · $13.0M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: San Diego
Employees: 1–10
Founded: 2022
Business Model: B2B

Website: aizentx.com
Total Funding: $13.0M
Last Round: $13.0M SeedNov 2024
Rounds: 1

About

Aizen is an AI-native biotechnology company pioneering oral peptides to transform the lives of patients and families burdened by chronic immune disorders. Powered by DaX, a foundational AI platform developed by Caltech faculty, the company designs de novo peptides that transcend natural biology through the chemical landscape of non-canonical amino acids. Headquartered in San Diego, Aizen is advancing a proprietary pipeline of gut-restricted and systemic oral biologics while collaborating with global biopharma partners.

Summary

Aizen Therapeutics is an Artificial Intelligence company based in San Diego, founded in 2022. It has raised $13.0M in total across 1 round, most recently a $13.0M Seed round in Nov 2024. Investors include Madrona Venture and Cercano Management.